Study details
Enrolling now
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
University of Minnesota
NCT IDNCT06058520ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
16
Study length
about 2.9 years
Ages
18+
Locations
1 site in MN
What this study is about
This trial is testing a treatment called fecal microbiota transplant (FMT) to see if it can change the gut microbiome in people with hidradenitis suppurativa (HS). The goal is to understand how changes in the gut microbiome might affect the skin condition.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Fecal Microbiota - lyophilized
- 2.Take Placebo drug
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in Hidradenitis Suppurativa quality of life (HiSQOL), Change in skin pain numerical rating scale (NRS)